{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T02:55:40Z","timestamp":1773370540511,"version":"3.50.1"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,1,3]],"date-time":"2026-01-03T00:00:00Z","timestamp":1767398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,3]],"date-time":"2026-01-03T00:00:00Z","timestamp":1767398400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"David C Koch Fund","award":["Philanthropic Funds"],"award-info":[{"award-number":["Philanthropic Funds"]}]},{"name":"ThermaSolutions","award":["Provided drug free of charge"],"award-info":[{"award-number":["Provided drug free of charge"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1245\/s10434-025-18966-3","type":"journal-article","created":{"date-parts":[[2026,1,3]],"date-time":"2026-01-03T09:47:08Z","timestamp":1767433628000},"page":"2993-3003","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Intra-Tumoral Mucolytic Therapy for Unresectable Pseudomyxoma Peritonei: Results of a Single-Center Expanded Access Program"],"prefix":"10.1245","volume":"33","author":[{"given":"Shannon","family":"Altpeter","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael M.","family":"Wach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erika","family":"Giran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joshua","family":"Derby","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott","family":"Beasley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James F.","family":"Pingpank","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melanie","family":"Ongchin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haroon A","family":"Choudry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,3]]},"reference":[{"key":"18966_CR1","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.1245\/s10434-018-6488-4","volume":"25","author":"HA Choudry","year":"2018","unstructured":"Choudry HA, Pai RK. Management of mucinous appendiceal tumors. Ann Surg Oncol. 2018;25:2135\u201344. https:\/\/doi.org\/10.1245\/s10434-018-6488-4. (PubMed PMID: 29717422 Epub 20180501).","journal-title":"Ann Surg Oncol"},{"key":"18966_CR2","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/S1470-2045(05)70539-8","volume":"7","author":"PH Sugarbaker","year":"2006","unstructured":"Sugarbaker PH. New standard of care for appendiceal epithelial neoplasms and pseudomyxoma peritonei syndrome? Lancet Oncol. 2006;7:69\u201376. https:\/\/doi.org\/10.1016\/S1470-2045(05)70539-8. (PubMed PMID: 16389186).","journal-title":"Lancet Oncol"},{"key":"18966_CR3","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/j.soc.2018.02.007","volume":"27","author":"KI Votanopoulos","year":"2018","unstructured":"Votanopoulos KI, Shen P, Skardal A, Levine EA. Peritoneal metastases from appendiceal cancer. Surg Oncol Clin North Am. 2018;27:551\u201361. https:\/\/doi.org\/10.1016\/j.soc.2018.02.007. (PubMedPMID: 29935689; PMCID: PMC8159158).","journal-title":"Surg Oncol Clin North Am"},{"key":"18966_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1200\/EDBK_321009","volume":"41","author":"RS Hoehn","year":"2021","unstructured":"Hoehn RS, Rieser CJ, Choudry MH, Melnitchouk N, Hechtman J, Bahary N. Current management of appendiceal neoplasms. Am Soc Clin Oncol Educ Book. 2021;41:1\u201315. https:\/\/doi.org\/10.1200\/EDBK_321009. (PubMed PMID: 33770459).","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"18966_CR5","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1245\/s10434-012-2241-6","volume":"19","author":"F Austin","year":"2012","unstructured":"Austin F, Mavanur A, Sathaiah M, Steel J, Lenzner D, Ramalingam L, et al. Aggressive management of peritoneal carcinomatosis from mucinous appendiceal neoplasms. Ann Surg Oncol. 2012;19:1386\u201393. https:\/\/doi.org\/10.1245\/s10434-012-2241-6. (PubMedPMID: 22302270; PMCID: PMC4100545).","journal-title":"Ann Surg Oncol"},{"key":"18966_CR6","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1002\/jso.23547","volume":"109","author":"AU Blackham","year":"2014","unstructured":"Blackham AU, Swett K, Eng C, Sirintrapun J, Bergman S, Geisinger KR, et al. Perioperative systemic chemotherapy for appendiceal mucinous carcinoma peritonei treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. J Surg Oncol. 2014;109:740\u20135. https:\/\/doi.org\/10.1002\/jso.23547. (Epub 20131228, PubMed PMID: 24375188; PMCID: PMC4010799).","journal-title":"J Surg Oncol"},{"key":"18966_CR7","doi-asserted-by":"publisher","unstructured":"Chicago Consensus Working G. The Chicago Consensus on Peritoneal Surface Malignancies: Management of appendiceal neoplasms. Ann Surg Oncol. 2020; 27:1753\u201360. https:\/\/doi.org\/10.1245\/s10434-020-08316-w. (Epub 20200413. PubMed PMID: 32285275)","DOI":"10.1245\/s10434-020-08316-w"},{"key":"18966_CR8","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1007\/s11605-019-04239-4","volume":"24","author":"V Narasimhan","year":"2020","unstructured":"Narasimhan V, Wilson K, Britto M, Warrier S, Lynch AC, Michael M, et al. Outcomes following cytoreduction and HIPEC for pseudomyxoma peritonei: 10-year experience. J Gastrointest Surg. 2020;24:899\u2013906. https:\/\/doi.org\/10.1007\/s11605-019-04239-4. (Epub 20190514. PubMed PMID: 31090036).","journal-title":"J Gastrointest Surg"},{"key":"18966_CR9","doi-asserted-by":"publisher","first-page":"101572","DOI":"10.1016\/j.suronc.2021.101572","volume":"38","author":"PA Sutton","year":"2021","unstructured":"Sutton PA, O\u2019Dwyer ST, Barriuso J, Aziz O, Selvasekar CR, Renehan AG, Wilson MS. Indications and outcomes for repeat cytoreductive surgery and heated intra-peritoneal chemotherapy in peritoneal surface malignancy. Surg Oncol. 2021;38:101572. https:\/\/doi.org\/10.1016\/j.suronc.2021.101572. (Epub 20210420. PubMed PMID: 33915487).","journal-title":"Surg Oncol."},{"key":"18966_CR10","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s12957-016-0804-x","volume":"14","author":"N Vassos","year":"2016","unstructured":"Vassos N, Fortsch T, Aladashvili A, Hohenberger W, Croner RS. Repeated cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with recurrent peritoneal carcinomatosis. World J Surg Oncol. 2016;14:42. https:\/\/doi.org\/10.1186\/s12957-016-0804-x. (Epub 20160224. PubMed PMID: 26912149; PMCID: PMC4765140).","journal-title":"World J Surg Oncol."},{"key":"18966_CR11","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1245\/s10434-019-07218-w","volume":"26","author":"HA Choudry","year":"2019","unstructured":"Choudry HA, Bednar F, Shuai Y, Jones HL, Pai RK, Pingpank JF, et al. Repeat cytoreductive surgery-hyperthermic intraperitoneal chemoperfusion is feasible and offers survival benefit in select patients with peritoneal metastases. Ann Surg Oncol. 2019;26:1445\u201353. https:\/\/doi.org\/10.1245\/s10434-019-07218-w. (Epub 20190301. PubMed PMID: 30825033; PMCID: PMC7170006).","journal-title":"Ann Surg Oncol."},{"key":"18966_CR12","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1634\/theoncologist.2014-0106","volume":"19","author":"F Pietrantonio","year":"2014","unstructured":"Pietrantonio F, Maggi C, Fanetti G, Iacovelli R, Di Bartolomeo M, Ricchini F, et al. FOLFOX-4 chemotherapy for patients with unresectable or relapsed peritoneal pseudomyxoma. Oncologist. 2014;19:845\u201350. https:\/\/doi.org\/10.1634\/theoncologist.2014-0106. (Epub 20140620. PubMed PMID: 24951608; PMCID: PMC4122474).","journal-title":"Oncologist"},{"key":"18966_CR13","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.16161","volume":"6","author":"JP Shen","year":"2023","unstructured":"Shen JP, Yousef AM, Zeineddine FA, Zeineddine MA, Tidwell RS, Beaty KA, et al. Efficacy of systemic chemotherapy in patients with low-grade mucinous appendiceal adenocarcinoma: a randomized crossover trial. JAMA Netw Open. 2023;6:e2316161. https:\/\/doi.org\/10.1001\/jamanetworkopen.2023.16161. (Epub 20230601. PubMed PMID: 37261831; PMCID: PMC10236240).","journal-title":"JAMA Netw Open"},{"key":"18966_CR14","doi-asserted-by":"publisher","first-page":"e1303","DOI":"10.1093\/oncolo\/oyad263","volume":"28","author":"J Dansby","year":"2023","unstructured":"Dansby J, More A, Zeineddine M, Yousef A, Bent A, Dayyani F, et al. Taxane-based chemotherapy is effective in metastatic appendiceal adenocarcinoma. Oncologist. 2023;28:e1303\u20135. https:\/\/doi.org\/10.1093\/oncolo\/oyad263. (PubMedPMID:37738316; PMCID:PMC10712908).","journal-title":"Oncologist."},{"key":"18966_CR15","doi-asserted-by":"publisher","first-page":"175883592211124","DOI":"10.1177\/17588359221112478","volume":"14","author":"MC Strach","year":"2022","unstructured":"Strach MC, Sutherland S, Horvath LG, Mahon K. The role of chemotherapy in the treatment of advanced appendiceal cancers: summary of the literature and future directions. Ther Adv Med Oncol. 2022;14:17588359221112478. https:\/\/doi.org\/10.1177\/17588359221112478. (Epub 20220723. PubMed PMID: 35898968; PMCID: PMC9310237).","journal-title":"Ther Adv Med Oncol."},{"key":"18966_CR16","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1002\/jso.23146","volume":"106","author":"HA Choudry","year":"2012","unstructured":"Choudry HA, O\u2019Malley ME, Guo ZS, Zeh HJ, Bartlett DL. Mucin as a therapeutic target in pseudomyxoma peritonei. J Surg Oncol. 2012;106:911\u20137. https:\/\/doi.org\/10.1002\/jso.23146. (Epub 20120514. PubMed PMID: 22585683).","journal-title":"J Surg Oncol."},{"key":"18966_CR17","first-page":"1522","volume":"13","author":"HK Wen","year":"2023","unstructured":"Wen HK, Valle SJ, Morris DL. Bromelain and acetylcysteine (BromAc[R])): a novel approach to the treatment of mucinous tumours. Am J Cancer Res. 2023;13:1522\u201332 (Epub 20230415. PubMed PMID: 37168359; PMCID: PMC10164791).","journal-title":"Am J Cancer Res."},{"key":"18966_CR18","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/1750-1172-9-71","volume":"9","author":"A Amini","year":"2014","unstructured":"Amini A, Masoumi-Moghaddam S, Ehteda A, Morris DL. Secreted mucins in pseudomyxoma peritonei: pathophysiological significance and potential therapeutic prospects. Orphanet J Rare Dis. 2014;9:71. https:\/\/doi.org\/10.1186\/1750-1172-9-71. (Epub 20140505. PubMed PMID: 24886459; PMCID: PMC4013295).","journal-title":"Orphanet J Rare Dis"},{"key":"18966_CR19","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1097\/01.MP.0000026617.52466.9F","volume":"15","author":"JT O\u2019Connell","year":"2002","unstructured":"O\u2019Connell JT, Hacker CM, Barsky SH. MUC2 is a molecular marker for pseudomyxoma peritonei. Mod Pathol. 2002;15:958\u201372. https:\/\/doi.org\/10.1097\/01.MP.0000026617.52466.9F. (PubMed PMID: 12218214).","journal-title":"Mod Pathol"},{"key":"18966_CR20","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/S0002-9440(10)64211-3","volume":"161","author":"JT O\u2019Connell","year":"2002","unstructured":"O\u2019Connell JT, Tomlinson JS, Roberts AA, McGonigle KF, Barsky SH. Pseudomyxoma peritonei is a disease of MUC2-expressing goblet cells. Am J Pathol. 2002;161:551\u201364. https:\/\/doi.org\/10.1016\/S0002-9440(10)64211-3. (PubMedPMID:12163380; PMCID:PMC1850719).","journal-title":"Am J Pathol."},{"key":"18966_CR21","doi-asserted-by":"publisher","first-page":"2060","DOI":"10.3390\/nu16132060","volume":"16","author":"U Kansakar","year":"2024","unstructured":"Kansakar U, Trimarco V, Manzi MV, Cervi E, Mone P, Santulli G. Exploring the therapeutic potential of bromelain: applications, benefits, and mechanisms. Nutrients. 2024;16:2060. https:\/\/doi.org\/10.3390\/nu16132060. (Epub 20240628. PubMed PMID: 38999808; PMCID: PMC11243481).","journal-title":"Nutrients"},{"key":"18966_CR22","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1007\/PL00000936","volume":"58","author":"HR Maurer","year":"2001","unstructured":"Maurer HR. Bromelain: biochemistry, pharmacology and medical use. Cell Mol Life Sci. 2001;58:1234\u201345. https:\/\/doi.org\/10.1007\/PL00000936. (PubMedPMID:11577981; PMCID:PMC11337410).","journal-title":"Cell Mol Life Sci."},{"key":"18966_CR23","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.ejpb.2023.12.001","volume":"194","author":"A Hocquigny","year":"2024","unstructured":"Hocquigny A, Hugerot H, Ghanem R, Haute T, Laurent V, Cogulet V, Montier T. Mucoactive drugs and multiple applications in pulmonary disease therapy. Eur J Pharm Biopharm. 2024;194:110\u20137. https:\/\/doi.org\/10.1016\/j.ejpb.2023.12.001. (Epub 20231202. PubMed PMID: 38048888).","journal-title":"Eur J Pharm Biopharm"},{"key":"18966_CR24","first-page":"265","volume":"80","author":"PJ Millea","year":"2009","unstructured":"Millea PJ. N-acetylcysteine: multiple clinical applications. Am Fam Physician. 2009;80:265\u20139 (PubMed PMID: 19621836).","journal-title":"Am Fam Physician."},{"key":"18966_CR25","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.3390\/antiox12091713","volume":"12","author":"D Mokra","year":"2013","unstructured":"Mokra D, Mokry J, Barosova R, Hanusrichterova J. Advances in the use of N-acetylcysteine in chronic respiratory diseases. Antioxidants Basel. 2013;12:1713. https:\/\/doi.org\/10.3390\/antiox12091713.","journal-title":"Antioxidants Basel"},{"key":"18966_CR26","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.trsl.2020.10.005","volume":"229","author":"AK Dilly","year":"2021","unstructured":"Dilly AK, Honick BD, Frederick R, Elapavaluru A, Velankar S, Makala H, et al. Improved chemosensitivity following mucolytic therapy in patient-derived models of mucinous appendix cancer. Transl Res. 2021;229:100\u201314. https:\/\/doi.org\/10.1016\/j.trsl.2020.10.005. (Epub 20201022 PubMed PMID: 33164812; PMCID: PMC7867596).","journal-title":"Transl Res"},{"key":"18966_CR27","first-page":"495","volume":"4","author":"J Akhter","year":"2014","unstructured":"Akhter J, Pillai K, Chua TC, Alzarin N, Morris DL. Efficacy of a novel mucolytic agent on pseudomyxoma peritonei mucin, with potential for treatment through peritoneal catheters. Am J Cancer Res. 2014;4:495\u2013507 (Epub 20140906. PubMed PMID: 25232491; PMCID: PMC4163614).","journal-title":"Am J Cancer Res."},{"key":"18966_CR28","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1002\/ijc.28380","volume":"134","author":"K Pillai","year":"2014","unstructured":"Pillai K, Akhter J, Chua TC, Morris DL. A formulation for in situ lysis of mucin secreted in pseudomyxoma peritonei. Int J Cancer. 2014;134:478\u201386. https:\/\/doi.org\/10.1002\/ijc.28380. (Epub 20130807. PubMed PMID: 23843173).","journal-title":"Int J Cancer."},{"key":"18966_CR29","first-page":"350","volume":"6","author":"A Amini","year":"2016","unstructured":"Amini A, Masoumi-Moghaddam S, Ehteda A, Liauw W, Morris DL. Potentiation of chemotherapeutics by bromelain and N-acetylcysteine: sequential and combination therapy of gastrointestinal cancer cells. Am J Cancer Res. 2016;6:350\u201369 (Epub 20160115. PubMed PMID: 27186409; PMCID: PMC4859666).","journal-title":"Am J Cancer Res."},{"key":"18966_CR30","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/s13046-014-0092-7","volume":"33","author":"A Amini","year":"2014","unstructured":"Amini A, Masoumi-Moghaddam S, Ehteda A, Morris DL. Bromelain and N-acetylcysteine inhibit proliferation and survival of gastrointestinal cancer cells in vitro: significance of combination therapy. J Exp Clin Cancer Res. 2014;33:92. https:\/\/doi.org\/10.1186\/s13046-014-0092-7. (Epub 20141112. PubMed PMID: 25425315; PMCID: PMC4245783).","journal-title":"J Exp Clin Cancer Res."},{"key":"18966_CR31","doi-asserted-by":"publisher","DOI":"10.1093\/bjs\/znae045","author":"L Rodriguez-Ortiz","year":"2024","unstructured":"Rodriguez-Ortiz L, Vazquez-Borrego MC, Bura FI, Granados-Rodriguez M, Valenzuela-Molina F, Rufian-Andujar B, et al. Intra-tumoural bromelain and N-acetylcysteine for recurrent and unresectable pseudomyxoma peritonei: phase I\/II trial. Br J Surg. 2024. https:\/\/doi.org\/10.1093\/bjs\/znae045. (PubMed PMID: 38477594).","journal-title":"Br J Surg."},{"key":"18966_CR32","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.ejso.2019.10.033","volume":"47","author":"SJ Valle","year":"2021","unstructured":"Valle SJ, Akhter J, Mekkawy AH, Lodh S, Pillai K, Badar S, et al. A novel treatment of bromelain and acetylcysteine (BromAc) in patients with peritoneal mucinous tumours: a phase I first in man study. Eur J Surg Oncol. 2021;47:115\u201322. https:\/\/doi.org\/10.1016\/j.ejso.2019.10.033. (Epub 20191031 PubMed PMID: 31679953).","journal-title":"Eur J Surg Oncol."},{"key":"18966_CR33","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1038\/modpathol.2014.37","volume":"27","author":"JM Davison","year":"2014","unstructured":"Davison JM, Choudry HA, Pingpank JF, Ahrendt SA, Holtzman MP, Zureikat AH, et al. Clinicopathologic and molecular analysis of disseminated appendiceal mucinous neoplasms: identification of factors predicting survival and proposed criteria for a three-tiered assessment of tumor grade. Mod Pathol. 2014;27:1521\u201339. https:\/\/doi.org\/10.1038\/modpathol.2014.37. (Epub 20140314 PubMed PMID: 24633196).","journal-title":"Mod Pathol."},{"key":"18966_CR34","doi-asserted-by":"publisher","unstructured":"Carr NJ, Cecil TD, Mohamed F, Sobin LH, Sugarbaker PH, Gonzalez-Moreno S, et al, Peritoneal Surface Oncology Group I. A consensus for classification and pathologic reporting of pseudomyxoma peritonei and associated appendiceal neoplasia: the results of the Peritoneal Surface Oncology Group International (PSOGI) modified Delphi process. Am J Surg Pathol. 2016;40:14\u201326. https:\/\/doi.org\/10.1097\/PAS.0000000000000535. (PubMed PMID: 26492181)","DOI":"10.1097\/PAS.0000000000000535"},{"key":"18966_CR35","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1002\/1097-0142(20010201)91:3<555::AID-CNCR1034>3.0.CO;2-F","volume":"91","author":"AH Dachman","year":"2001","unstructured":"Dachman AH, MacEneaney PM, Adedipe A, Carlin M, Schumm LP. Tumor size on computed tomography scans: is one measurement enough? Cancer. 2001;91:555\u201360 (PubMed PMID: 11169938).","journal-title":"Cancer"},{"key":"18966_CR36","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","volume":"240","author":"D Dindo","year":"2004","unstructured":"Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240:205\u201313. https:\/\/doi.org\/10.1097\/01.sla.0000133083.54934.ae. (PubMedPMID: 15273542; PMCID:PMC1360123).","journal-title":"Ann Surg."},{"key":"18966_CR37","doi-asserted-by":"publisher","first-page":"33329","DOI":"10.18632\/oncotarget.5259","volume":"6","author":"A Amini","year":"2015","unstructured":"Amini A, Masoumi-Moghaddam S, Ehteda A, Liauw W, Morris DL. Depletion of mucin in mucin-producing human gastrointestinal carcinoma: results from in vitro and in vivo studies with bromelain and N-acetylcysteine. Oncotarget. 2015;6:33329\u201344. https:\/\/doi.org\/10.18632\/oncotarget.5259. (PubMed PMID:26436698; PMCID:PMC4741769).","journal-title":"Oncotarget"},{"key":"18966_CR38","doi-asserted-by":"publisher","first-page":"7909","DOI":"10.2147\/CMAR.S324982","volume":"13","author":"YL Lin","year":"2021","unstructured":"Lin YL, Li Y. The biological synthesis and the function of mucin 2 in pseudomyxoma peritonei. Cancer Manag Res. 2021;13:7909\u201317. https:\/\/doi.org\/10.2147\/CMAR.S324982. (Epub 20211015. PubMed PMID: 34703312; PMCID: PMC8527350).","journal-title":"Cancer Manag Res."},{"key":"18966_CR39","doi-asserted-by":"publisher","first-page":"18","DOI":"10.7150\/ijms.16422","volume":"14","author":"K Pillai","year":"2017","unstructured":"Pillai K, Akhter J, Mekkawy A, Chua TC, Morris DL. Physical and chemical characteristics of mucin secreted by pseudomyxoma peritonei (PMP). Int J Med Sci. 2017;14:18\u201328. https:\/\/doi.org\/10.7150\/ijms.16422. (Epub 20170101. PubMed PMID: 28138305; PMCID: PMC5278655).","journal-title":"Int J Med Sci."},{"key":"18966_CR40","doi-asserted-by":"publisher","first-page":"2875","DOI":"10.26355\/eurrev_202204_28619","volume":"26","author":"V Granata","year":"2022","unstructured":"Granata V, Fusco R, Venanzio Setola S, Sassaroli C, De Franciscis S, Delrio P, et al. Radiological assessment of peritoneal carcinomatosis: a primer for resident. Eur Rev Med Pharmacol Sci. 2022;26:2875\u201390. https:\/\/doi.org\/10.26355\/eurrev_202204_28619. (PubMed PMID: 35503632).","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"18966_CR41","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.62347\/HQJH9945","volume":"15","author":"AH Mekkawy","year":"2025","unstructured":"Mekkawy AH, Breakeit M, Rahman MK, Pillai K, Solanki A, Octavia F, et al. Safety of BromAc((R)) with mitomycin C during hyperthermic intraperitoneal chemotherapy (HIPEC): a preclinical study. Am J Cancer Res. 2025;15:1213\u201323. https:\/\/doi.org\/10.62347\/HQJH9945.","journal-title":"Am J Cancer Res."},{"key":"18966_CR42","doi-asserted-by":"publisher","first-page":"5377","DOI":"10.1245\/s10434-024-15355-0","volume":"31","author":"N Wajih","year":"2024","unstructured":"Wajih N, Erali RA, Forsythe SD, Schaaf CR, Shen P, Levine EA, et al. Enhancing the efficacy of HIPEC through bromelain: a preclinical investigation in appendiceal cancer. Ann Surg Oncol. 2024;31:5377\u201389. https:\/\/doi.org\/10.1245\/s10434-024-15355-0. (Epub 20240504. PubMed PMID: 38704503; PMCID: PMC11236891).","journal-title":"Ann Surg Oncol"},{"key":"18966_CR43","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1007\/s00261-018-1752-4","volume":"44","author":"B Morse","year":"2019","unstructured":"Morse B, Jeong D, Ihnat G, Silva AC. Pearls and pitfalls of response evaluation criteria in solid tumors (RECIST) v1.1 non-target lesion assessment. Abdom Radiol NY. 2019;44:766\u201374. https:\/\/doi.org\/10.1007\/s00261-018-1752-4. (PubMed PMID: 30196362; PMCID: PMC7771310).","journal-title":"Abdom Radiol NY"}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-025-18966-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-025-18966-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-025-18966-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T15:47:09Z","timestamp":1773330429000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-025-18966-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,3]]},"references-count":43,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["18966"],"URL":"https:\/\/doi.org\/10.1245\/s10434-025-18966-3","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,3]]},"assertion":[{"value":"12 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors have no relevant conflicts of interest to declare.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}}]}}